A third consecutive year of deferred NIM recovery — but a fund-liquidation question and a fee engine quietly doing the heavy lifting are the real news
AKBNK.IS · Earnings Call · 2026-10-27
The trough that keeps moving
Akbank's third-quarter call opened with the sentence that has become a seasonal ritual in Istanbul: “third quarter marked a trough in our NIM, setting the stage for a gradual recovery” — Ebru Güvenir, CFO · 2026-10-27. Nine-month cumulative quarterly NIM sits near 2.8% against a full-year guidance band of 3.2%–3.5%, and CFO Türker Tunalı was candid that the arithmetic no longer quite closes: “we may end the year slightly below full-year guidance” — Türker Tunalı, CFO or Senior Executive (likely CFO) · 2026-10-27.
That sentence has a history. In October 2025, on the equivalent call, the same executive told investors of that year's NIM guidance: “it's very likely that we may like stay behind this” — Türker Tunali, CFO or Finance Executive · 2025-10-24. In July 2026 the promise was re-dated forward — “we expect gradual improvement in the net interest margin towards the end of third quarter and maybe mainly in the fourth quarter that we can reach this guidance” — Türker Tunali, Executive/Management · 2026-07-28. Three consecutive reports, three deferrals, each with a structurally sound explanation. The pattern, not the quarter, is the signal.
We will actually do our best in the fourth quarter to come close to this guidance of 23%-25%, but definitely it will be challenging.
What makes this quarter's version different is the mechanism. The culprit is not loan pricing or deposit competition in the abstract — it is a CPI-linked accounting assumption. Management had raised its October-to-October inflation assumption from 25% to 30% in the second quarter, then cut it to 29.5% in the third, and “we revised our October-to-October CPI estimation downwards to 29.5%, which put additional pressure on our quarterly NIM” — Ebru Güvenir, CFO · 2026-10-27. Success on disinflation mechanically hurt reported margin. That is a real tension worth naming: Akbank is being penalised in the near term for the very outcome its entire 2027 thesis depends on.
The plumbing: a fund liquidation nobody has fully priced
The genuinely new item on this call had nothing to do with the deck. Analyst David Taranto asked about disruption in the Turkish money market fund complex — liquidation flows, deposit spill-over, asset-quality contagion, and whether the loan-growth-cap exemption for corporate bond refinancing opens a lending door. This theme is absent from the prior five Q&A sections in the record.
The answer was reassuring and slightly unresolved in equal measure: “we've seen some inflows into our deposit base, but I can't say that it's really huge” — Türker Tunalı, CFO or Senior Executive (likely CFO) · 2026-10-27. Management says it has stress-checked borrowers who were also fund investors and found the overlap immaterial, and that the liquidation process is still ongoing. For a bank that leans on a funding cost advantage narrative, a domestic shadow-banking unwind is precisely the kind of second-order risk that does not show up in a Stage 2 ratio for a quarter or two.
Funding cost is the one thing Akbank shares with everybody
This quarter's keyword slate reads like a sector confession rather than a company story. funding cost is Akbank's single highest-ranked theme, and the identical phrase appears across the current reporting set — Korean regional banks, Standard Chartered, HSBC, Webster, First Bancorp, Dutch and Nordic lenders. cost of credit likewise. The message: elevated liability costs squeezing margin is the global banking condition of late 2026, not an Akbank execution failure. The market-wide tape reinforces the direction of travel — global bank and rate-sensitive themes have been fading over the 90-day window, with "deposit cost", "rate environment" and "higher interest rates" all clustering in the decliners.
What is not shared is the fee engine, and it deserves more credit than the headline ROE miss. Nine-month fee income grew 23% year-on-year against 35% operating expense growth, with wealth management fees up 60% (Ak Portföy now at 12% share among private institutions), bancassurance up 35% with roughly 80% of insurance sales digital, and money transfer fees up 44%. That delivered a 95% nine-month fee-to-OpEx coverage ratio and 97% in the quarter alone. For a bank whose own strategic ambition is a ~100% ratio, the fee base is now effectively self-funding the branch network — a structural change that predates and will outlast this rate cycle.
Capital: the IRB promise, third time lucky?
One elegant confluence with the global keyword set: IRB model is the second-highest-ranked theme across the entire market this quarter, carried by Swedish and Baltic lenders. Akbank is riding the same regulatory wave — and it is the single largest identifiable catalyst on the equity story. The problem is that the promise has not moved: “the uplift we are going to get from switch to IRB from standard approach will be around 2%” — Türker Tunalı, CFO or Senior Executive (likely CFO) · 2026-10-27 into all capital ratios. That is verbatim the same quantum promised in July 2026 (“we can expect around 2% uplift to our capital ratio” — Türker Tunali, Executive/Management · 2026-07-28) and in February, while the timeline has slipped from "somewhere next year" to "probably the first half of 2027." A CET1 of 11.2% and total capital of 16.7% are comfortable, but the 2% uplift is doing an enormous amount of work in every bull model — and it keeps arriving later.
Meanwhile the balance-sheet rotation is genuinely underway: TL loans up 21% year-to-date, FX loans up 8% with a 60bp share gain among private banks, the TL loan share of TL assets up 8 percentage points since 2024 to 60%, and business loans now 64% of the book, up 3pp. Crucially, the reinvestment leg is deferred — the upcoming redemptions of negative-carry TL securities do not bite until the second half of 2027, which means the asset-side NIM kicker is a 2027 story stacked on top of a 2027 disinflation story stacked on top of a 2027 IRB story. Everything good about Akbank now lives in 2027.
What management stopped saying
Two absences are louder than any addition. First, "real ROE" — a top-five keyword in the January 2026 quarter, when management framed a 10% real-return ambition — has vanished from the current slate, replaced by apologetic nominal guidance. Second, NPL formation and stress-testing themes have disappeared almost entirely; asset quality is now narrated as outperformance rather than defence, with NPL market share down 210bp year-to-date and 470bp since the start of last year, Stage 2+3 at 11.9%, restructured loans at 3.9%, and Stage 2+3 coverage at a sturdy 26.7%. Cost of credit at 189bp for nine months, with a 20bp model-update tailwind, still lands inside the 200bp guidance. That is a real franchise asset — and it is the reason the dour margin tone never becomes a solvency story.
No price tape was available for this name in the dataset, so we cannot verify whether the market has already discounted the third deferral. What we can say is that the exit commentary is the most concrete management has offered in a year: fourth-quarter run-rate NIM above 3.2%, exiting into 2027 above 3.5%, a blended marginal deposit cost near 36% and big-ticket pricing capped around 37%, with the December MPC described as roughly a coin flip. If that exit number prints, the trough finally stays put. If it slips again, investors should stop treating the trough as a date and start treating it as a moving average.